SavedAdd your journal

Journals / Bozok Tıp Dergisi / 2026 / Cilt: 14 Sayı: 2

A LOOK AT THYROID FUNCTIONS AS A PREDICTOR ON PROGNOSIS OF CRITICALLY ILL PATIENTS IN INTENSIVE CARE UNITS FROM THE PERSPECTIVE OF COVID-19 Yoğun Bakım Ünitesindeki Kritik Hastaların Prognozunun Belirleyicisi Olarak Tiroid Fonksiyonlarına Covid-19 Perspektifinden Bir Bakış

Murat Tümer(VKV Amerikan Hastanesi)
Nihal Deniz Bulut Yüksel(Mersin Şehir Hastanesi)
Banu Kılıçaslan(HACETTEPE UNIVERSITY)
Seda Banu Akıncı(HACETTEPE ÜNİVERSİTESİ)
Pages
113–119
Publication Date
2024-06-14
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the future, a broader panel of validated biochemical markers, including fT3 levels, may become a simple tool for stratified management of patients with severe COVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACT Objective: Thyroid gland can be affected both by cytokine storm and through angiotensin-converting enzyme 2 receptors.
📊
Key Findings & Data:A worse prognosis has been described in patients with low fT3 levels.
💡
Conclusion & Impact:In the future, a broader panel of validated biochemical markers, including fT3 levels, may become a simple tool for stratified management of patients with severe COVID-19.
🔬Design:Araştırma Makalesi
📍Scope:2020 Verileri
⚙️Variables:A LOOK AT THYROID FUNCTIONS AS A PREDICTOR ON PROGNOSIS OF CRITICALLY ILL PATIENTS IN INTENSIVE CARE UNITS FROM THE PERSPECTIVE OF COVID-19 · Yoğun Bakım Ünitesindeki Kritik Hastaların Prognozunun Belirleyicisi Olarak Tiroid Fonksiyonlarına Covid-19 · Perspektifinden Bir Bakış

Özet

ABSTRACT Objective: Thyroid gland can be affected both by cytokine storm and through angiotensin-converting enzyme 2 receptors. A worse prognosis has been described in patients with low fT3 levels. The aim of this study is to evaluate the prognostic significance of thyroid function during COVID-ICU hospitalization. Material and Methods: After ethical approval, 100 COVID-19 patients followed in the ICU between March 2020 and April 2021 was admitted to study. Patients with previous thyroid disease were excluded from study. Free triiodothyronine (fT3), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) levels at ICU admission were evaluated. Clinical, demographic, laboratory, treatment, and outcome data were obtained from the patient's electronic hospital records. Mann Whitney U, Spearman correlation, binary logistic, and linear regression tests were used for statistical analysis. Results: TSH was in 31 patients, fT3 was in 37 patients, and fT4 was in 54 patients, which were outside the normal ranges. fT3 were lower in non-survivors than the survivors (p=0.036). However, the fT3 level was not the independent factor for mortality rate in linear regression analysis (p=0.652). APACHE II and procalcitonin levels as independent predictors of mortality (p=0.017). fT3 remained an independent factor for the length of ICU stay (p=0.024) and the length of hospital stay (p=0.031). Conclusion: fT3 is a prognostic indicator that can predict hospital and ICU length of stay in critically ill patients with Covid-19. In the future, a broader panel of validated biochemical markers, including fT3 levels, may become a simple tool for stratified management of patients with severe COVID-19.

🔖

Cite This Article

Tümer, M., Yüksel, N. D. B., Kılıçaslan, B., Akıncı, S. B. (2024). A LOOK AT THYROID FUNCTIONS AS A PREDICTOR ON PROGNOSIS OF CRITICALLY ILL PATIENTS IN INTENSIVE CARE UNITS FROM THE PERSPECTIVE OF COVID-19 Yoğun Bakım Ünitesindeki Kritik Hastaların Prognozunun Belirleyicisi Olarak Tiroid Fonksiyonlarına Covid-19 Perspektifinden Bir Bakış. Bozok Tıp Dergisi, Cilt: 14 Sayı: 2, 113–119. https://doi.org/10.16919/bozoktip.1416323

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020; 21:1–13.
  2. Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020; 9(1):45
  3. Ippolito S, Dentali F. Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020; 43 (8):1171–2.
  4. Wei L, Sun S, Xu CH, Zhang J, Xu Y, Zhu H, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol. 2007; 38(1): 95–102.
  5. Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2021;106(2): e926–e935.
  6. Lisco G, De Tullio A, Stragapede A, Solimando AG, Albanese F, Capobianco M, et al. COVID-19 and the endocrine system: a comprehensive review on the theme. J Clin Med 2021, 10(13):2920.
  7. Llamas M, Garo ML, Giovanella L. Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis. Clin Chem Lab Med 2021; 59(12): 1906–13
  8. Campi I, Bulgarelli I, Dubini A, Perego GB, Tortorici E, Torlasco C, et al. The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection. Eur J Endocrinol 2021; 184(5):699–709.
  9. Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G, et al. Thyroid hormone concen- trations in severely or critically ill patients with COVID-19. J Endocrinol Invest 2021; 44(5):1031–40.
  10. Schwarz Y, Percik R, Oberman B, Yaffe D, Zimlichman E, Tirosh A. Sick euthyroid syndrome on presentation of patients with COVID-19: a potential marker for disease severity. Endocr Pract 2021; 27 (2):101–9.